[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100424814":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":28,"locations":34,"responsibleParty":58,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":10,"maxAge":10,"enrollmentInfo":69,"targetDuration":72,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Kantonsspital Aarau","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A (largest part of the cohort)",null,"Children, adolescents, and adults who are still in follow-up care (data are collected retrospectively until 2016 at the most)",[13,14],"Other: Physical examination, diagnostic tests, laboratory tests","Other: Personal history",{"label":16,"type":10,"description":17,"interventionNames":18},"Group B (very small part of the cohort)","Children, adolescents, and adults who left follow-up care (data are collected retrospectively until 2016 at the most)",[13,14],[20,24],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Physical examination, diagnostic tests, laboratory tests","Physical examination, diagnostic tests (e.g. lung function test, echocardiography, audiometry), and laboratory tests (e.g. kidney parameter, hormonal levels) depend on examined organ system.",[9,16],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"Personal history","Personal history on diagnosis, treatment, and socioeconomic factors",[9,16],[29],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Katrin Scheinemann, MD","CONTACT","+41628384909","katrin.scheinemann@ksa.ch",[35],{"facility":36,"status":37,"city":38,"state":10,"zip":10,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau","RECRUITING","Aarau","Switzerland","CH",{"type":42,"coordinates":43},"Point",[44,45],8.04422,47.39254,{"lat":45,"lon":44},[48,49,51,54,56],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},{"name":30,"role":50,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"name":52,"role":53,"phone":10,"phoneExt":10,"email":10},"Maria Otth, MD","SUB_INVESTIGATOR",{"name":55,"role":53,"phone":10,"phoneExt":10,"email":10},"Daniel Drozdov, MD",{"name":57,"role":53,"phone":10,"phoneExt":10,"email":10},"Claudia Huegli, MD",{"type":50,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Katrin Scheinemann","Division Head of Pediatric Oncology-Hematology","100424814","young-survivors-at-kantonsspital-aarau-switzerland-100424814",false,"NCT04811794","Young Survivors at Kantonsspital Aarau, Switzerland","Young Survivors at Kantonsspital Aarau, Switzerland - A Standardized Assessment of Long-Term and Late-Onset Health Events in Survivors of Childhood and Adolescent Cancer","Inclusion Criteria:\n\nGroup A:\n\nChildren and adolescents who:\n\n* have been treated for cancer in the Division of Oncology-Hematology, Department of Pediatrics, at the Kantonsspital Aarau,\n* have been diagnosed at age 0-18 years,\n* are still in regular follow-up care at the Kantonsspital Aarau,\n* have finished cancer treatment and entered follow-up care, and\n* signed informed consent\n\nGroup B:\n\nAdolescents and adults who:\n\n* fulfill the same inclusion criteria as Group A\n* are not in regular follow-up care anymore\n\nExclusion Criteria:\n\nChildhood Cancer Survivors who:\n\n* are in a palliative situation or\n* have not given consent for further use of medical data","ALL",{"count":70,"type":71},300,"ESTIMATED","50 Years","OBSERVATIONAL","The Young Survivors at Kantonsspital Aarau project assesses the prevalence and severity of late effects in survivors of childhood and adolescent cancer according to the modified CTCAE criteria prospectively. The clinical data are generated during regular follow-up care visits, the collection starts directly after completion of treatment and is longitudinally.",[76,77],"Childhood Cancer","Late Effects",[76,79,77,80],"Survivor","CTCAE","2022-08-16",{"date":83,"type":84},"2022-08-17","ACTUAL",{"date":86,"type":84},"2021-03-15",{"date":88,"type":71},"2072-03-15",{"name":5,"class":6},1]